Cardiome Pharma Corporation (CRME)
Cardiome Pharma Corporation Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 0.40M | 0.30M | 0.40M | 0.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 0.40M | 0.30M | 0.40M | 0.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Research & Development Expense | 3.45M | 3.90M | 4.07M | 3.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Selling, General, & Admin. Expense | 2.10M | 2.76M | 3.46M | 3.22M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Depreciation & Amortization | 0.27M | 0.27M | 0.28M | 0.27M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 5.82M | 6.93M | 7.81M | 7.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Operating Income | -5.42M | -6.63M | -7.41M | -6.89M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Non-Operating Income | -0.48M | -0.49M | -0.35M | -0.23M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Pretax Income | -6.55M | -7.15M | -7.72M | -7.14M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Provision for Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Income after Tax | -6.55M | -7.15M | -7.72M | -7.14M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -5.90M | -7.20M | -7.70M | -7.10M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Income | -5.92M | -7.20M | -7.70M | -7.10M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 59.00 | 60.00 | 59.23 | 59.17 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Average Shares used to compute basic EPS | 59.00 | 60.00 | 59.23 | 59.17 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| EPS - Basic net | -0.10 | -0.12 | -0.13 | -0.12 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| EPS - Diluted net | -0.10 | -0.12 | -0.13 | -0.12 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
